Medtronic’s Infuse bone grafts have been used on patients across the globe. However, Medtronic is under an FDA investigation and is the target of patient and surgeon complaints.
Medtronic’s Infuse was designed to help fill in spaces where bone is missing, fractured or otherwise required. The FDA approved Infuse in 2002 for certain spinal surgeries, including spinal fusion. It was later approved for traumatic tibia injuries in 2004 and for certain dental procedures in 2007.
Medtronic has since been accused of altering studies and the results of its product. These Infuse bone grafts have been linked to serious health concerns, including an increased risk of cancer. Other potential side effects from the Medtronic Infuse include:
Patients who have received Infuse may be able to work with a defective product lawyer to file a lawsuit to receive compensation. Many have already taken action against Medtronic for designing a defective product and fraudulently misrepresenting its product to the public. Nonetheless, Medtronic has failed to issue a recall.
Goldblatt + Singer has served injured individuals for more than 60 years and has sought full compensation for more than 25,000 clients during that time. Contact Goldblatt + Singer or call us toll-free.
fields required *